BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15660415)

  • 1. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
    Pardo M; Piñeiro A; de la Fuente M; García A; Prabhakar S; Zitzmann N; Dwek RA; Sánchez-Salorio M; Domínguez F; Capeans C
    J Cell Biochem; 2004 Nov; 93(4):708-20. PubMed ID: 15660415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes.
    Mouriaux F; Casagrande F; Pillaire MJ; Manenti S; Malecaze F; Darbon JM
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):876-84. PubMed ID: 9579467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclin-dependent kinase inhibitory proteins in normal and transformed choroidal melanocytes].
    Mouriaux F; Maurage CA; Labalette P; Casagrande F; Malecaze F; Darbon JM
    J Fr Ophtalmol; 1999 Apr; 22(3):339-46. PubMed ID: 10337591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
    Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
    Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival.
    Yu BD; Becker-Hapak M; Snyder EL; Vooijs M; Denicourt C; Dowdy SF
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14881-6. PubMed ID: 14630948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of RASSF1A in uveal melanocytes and melanoma cells.
    Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
    Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma cell autonomous growth: the Rb/E2F pathway.
    Halaban R
    Cancer Metastasis Rev; 1999; 18(3):333-43. PubMed ID: 10721488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
    de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
    Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors and melanomas.
    Halaban R
    Semin Oncol; 1996 Dec; 23(6):673-81. PubMed ID: 8970586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Deregulation of cell cycle control in lung cancer].
    Toyoshima H
    Nihon Rinsho; 2000 May; 58(5):1031-5. PubMed ID: 10824544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
    Enomoto K; Mimura T; Harris DL; Joyce NC
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
    Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
    Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
    Sabah M; Cummins R; Leader M; Kay E
    Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
    Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
    In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.